Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial

R. L. O. van de Laar*, W. Hofhuis, R. G. Duijnhoven, S. Polinder, W. J. G. Melchers, F. J. van Kemenade, R. L. M. Bekkers, H. J. Van Beekhuizen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number539
Number of pages7
JournalBMC Cancer
Volume20
Issue number1
DOIs
Publication statusPublished - 9 Jun 2020

Keywords

  • Cervical intraepithelial neoplasia (CIN)
  • HSIL
  • Human papillomavirus (HPV)
  • Loop electrosurgical excision procedure (LEEP)
  • HPV-vaccination
  • Recurrence
  • Persistence
  • HUMAN-PAPILLOMAVIRUS
  • GRADE 3
  • CANCER
  • RISK

Cite this

van de Laar, R. L. O., Hofhuis, W., Duijnhoven, R. G., Polinder, S., Melchers, W. J. G., van Kemenade, F. J., Bekkers, R. L. M., & Van Beekhuizen, H. J. (2020). Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial. BMC Cancer, 20(1), [539]. https://doi.org/10.1186/s12885-020-07025-7